Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-9601N

Copy Product Info
😃Good
Catalog No. T8849Cas No. 133845-63-3

PF-9601N showed high potency and selectivity as a MAO-BI (monoamine oxidase type B inhibitor) and also demonstrated remarkable neuroprotective properties in several in vivo and cellular models of PD.

PF-9601N

PF-9601N

Copy Product Info
😃Good
Purity: 98.29%
Catalog No. T8849Cas No. 133845-63-3
PF-9601N showed high potency and selectivity as a MAO-BI (monoamine oxidase type B inhibitor) and also demonstrated remarkable neuroprotective properties in several in vivo and cellular models of PD.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$43In StockIn Stock
10 mg$71In StockIn Stock
25 mg$148In StockIn Stock
50 mg$238In StockIn Stock
100 mg$353In StockIn Stock
200 mg$493-In Stock
1 mL x 10 mM (in DMSO)$43In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.29%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

PF-9601N AI Summary
PF-9601N exhibits significant bioactivity as a monoamine oxidase (MAO) inhibitor, targeting both MAO-A and MAO-B enzymes. For human MAO-A, it shows an IC50 value of 287.3 nM, while for human MAO-B, it has a much lower IC50 value of 4.1 nM, indicating higher potency and selectivity towards MAO-B. Similarly, for rat enzymes, it displays IC50 values of 1250.0 nM for MAO-A and 22.0 nM for MAO-B. The Ki values for Monoamine oxidase B are 794.33 nM and as low as 0.75 nM, further underscoring its strong inhibitory effect, whereas the Ki values for Monoamine oxidase A span 790.0 nM. This compound does not show significant activity against acetylcholinesterase and butyrylcholinesterase, with IC50 values exceeding 100,000.0 nM. The inhibition profile of PF-9601N suggests that it has potential therapeutic implications for conditions associated with MAO-B, such as neurodegenerative diseases, by modulating neurotransmitter levels like serotonin and phenylethylamine..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PF-9601N showed high potency and selectivity as a MAO-BI (monoamine oxidase type B inhibitor) and also demonstrated remarkable neuroprotective properties in several in vivo and cellular models of PD.
Chemical Properties
Molecular Weight290.36
FormulaC19H18N2O
Cas No.133845-63-3
SmilesC#CCNCc1cc2cc(OCc3ccccc3)ccc2[nH]1
Relative Density.1.185 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 25 mg/mL (86.1 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4440 mL17.2200 mL34.4400 mL172.2000 mL
5 mM0.6888 mL3.4440 mL6.8880 mL34.4400 mL
10 mM0.3444 mL1.7220 mL3.4440 mL17.2200 mL
20 mM0.1722 mL0.8610 mL1.7220 mL8.6100 mL
50 mM0.0689 mL0.3444 mL0.6888 mL3.4440 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-9601N | purchase PF-9601N | PF-9601N cost | order PF-9601N | PF-9601N chemical structure | PF-9601N formula | PF-9601N molecular weight